The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Healthequity Inc (NASDAQ: HQY) closed at $90.95 down -0.07% from its previous closing price of $91.01. In other words, the price has decreased by -$0.07 from its previous closing price. On the day, 1.28 million shares were traded. HQY stock price reached its highest trading level at $92.355 during the session, while it also had its lowest trading level at $90.77.
Ratios:
For a deeper understanding of Healthequity Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.32 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.29. For the most recent quarter (mrq), Quick Ratio is recorded 4.06 and its Current Ratio is at 4.06. In the meantime, Its Debt-to-Equity ratio is 0.52 whereas as Long-Term Debt/Eq ratio is at 0.52.
On March 25, 2025, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also lowered its target price recommendation from $120 to $115.
On December 04, 2024, Mizuho started tracking the stock assigning a Outperform rating and target price of $126.Mizuho initiated its Outperform rating on December 04, 2024, with a $126 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 03 ’25 when Delano Ladd bought 970 shares for $100.87 per share.
James M. Lucania bought 2,375 shares of HQY for $239,571 on Jul 03 ’25. On Jul 03 ’25, another insider, Stephen Neeleman, who serves as the Officer of the company, bought 1,049 shares for $100.87 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HQY now has a Market Capitalization of 7864937472 and an Enterprise Value of 8683797504. As of this moment, Healthequity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 66.20, and their Forward P/E ratio for the next fiscal year is 20.66. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.33 while its Price-to-Book (P/B) ratio in mrq is 3.71. Its current Enterprise Value per Revenue stands at 6.986 whereas that against EBITDA is 21.404.
Stock Price History:
The Beta on a monthly basis for HQY is 0.52, which has changed by 0.26459956 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, HQY has reached a high of $116.65, while it has fallen to a 52-week low of $67.00. The 50-Day Moving Average of the stock is -9.65%, while the 200-Day Moving Average is calculated to be -6.84%.
Shares Statistics:
For the past three months, HQY has traded an average of 1.04M shares per day and 945170 over the past ten days. A total of 86.71M shares are outstanding, with a floating share count of 84.61M. Insiders hold about 2.16% of the company’s shares, while institutions hold 106.76% stake in the company. Shares short for HQY as of 1752537600 were 5432595 with a Short Ratio of 5.24, compared to 1749772800 on 5262496. Therefore, it implies a Short% of Shares Outstanding of 5432595 and a Short% of Float of 7.2700000000000005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating of Healthequity Inc (HQY) is currently shaped by the ongoing analysis conducted by 12.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.9, with high estimates of $0.96 and low estimates of $0.85.
Analysts are recommending an EPS of between $3.85 and $3.63 for the fiscal current year, implying an average EPS of $3.73. EPS for the following year is $4.42, with 12.0 analysts recommending between $4.55 and $4.28.
Revenue Estimates
A total of 13 analysts believe the company’s revenue will be $320.69M this quarter.It ranges from a high estimate of $327.24M to a low estimate of $313.56M. As of the current estimate, Healthequity Inc’s year-ago sales were $299.93MFor the next quarter, 13 analysts are estimating revenue of $319.51M. There is a high estimate of $326.19M for the next quarter, whereas the lowest estimate is $314.8M.
A total of 14 analysts have provided revenue estimates for HQY’s current fiscal year. The highest revenue estimate was $1.32B, while the lowest revenue estimate was $1.3B, resulting in an average revenue estimate of $1.3B. In the same quarter a year ago, actual revenue was $1.2BBased on 13 analysts’ estimates, the company’s revenue will be $1.42B in the next fiscal year. The high estimate is $1.46B and the low estimate is $1.4B.
